RNA Analysis Market Share, Size, Analysis, Forecast, 2031

RNA Analysis Market Research,2031

RNA Analysis Market to surpass USD 14.12 billion by 2031 from USD 4.96 billion in 2021 at a CAGR of 12.4% throughout the forecast period 2022-31

The study of the transcriptome, or the entire collection of RNA analysis generated by the genome under specific conditions in a given environment or in a given cell using high-throughput technologies such as microarray analysis, is known as RNA analysis. The technique of RNA sequencing is widely used for determining gene expression levels. It's a versatile method for detecting and characterising gene expression, mutations, gene fusions, and noncoding RNAs, among others.

Market Highlights

Global RNA Analysis market is expected to project a notable CAGR of 12.4% in 2031.

Global RNA Analysis to surpass USD 14.12 billion by 2031 from USD 4.96 billion in 2021 at a CAGR of 12.4% in the coming years, i.e., 2021-31. The increasing demand for personalised medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market are driving the growth of this market. The growing emphasis on biomarker discovery and toxicogenomics, as well as the growing interest in outsourcing services, are expected to offer lucrative growth opportunities for players in the global RNA analysis market

Figure - Market Analysis of Global RNA Analysis Market

Get More Information - Download Free Sample

Global RNA Analysis: Segments

Consumables segment to grow with the highest CAGR during 2021-31

Global RNA Analysis market is classified on the basis of Type into Consumables, Instruments, Software and Services. The growing demand for high-quality reagents, as well as the frequent use of media and consumables in transcriptome studies is expected to increase growth of the consumables segment. Furthermore, rising R&D activities in the pharmaceutical industry, rising government investments in life science research, and rising research with integrated omics studies are all contributing to the market for consumables.

Drug Discovery segment to grow with the highest CAGR during 2021-31

Based on application, global RNA Analysis Market is fragmented into Clinical Diagnostics, Drug Discovery, Toxicogenomics and Comparative Transcriptomics. The use of transcriptomics in drug discovery for target identification and validation, identification of efficacy and toxicity biomarkers from biological fluids, and investigation of drug action and toxicity mechanisms is attributed to the growth in this segment. The increased need to study a large number of genes in order to gain a better understanding of gene-to-drug interactions is also expected to drive the use of transcriptomic technologies in drug discovery applications.

Figure - Market Analysis of Global Vaccine Technologies Market

Market Dynamics

Drivers

Rising demand for RNA applications and customized treatment

The market is expected to grow due to rising demand for customised treatment and RNA sequencing applications in transcriptomics. The RNA analysis market is expected to grow significantly over the forecast period due to rapid advancements in the transcriptomics sector. The growing emphasis on biomarker development and toxicogenomic research are likely to provide significant potential opportunities for global RNA analysis market participants.

Interest in outsourcing services and improvement in R&D

The growing interest in outsourcing services, as well as the increased emphasis on biomarker discovery and toxicogenomic research, is likely to provide significant growth opportunities for global market participants. Furthermore, rising pharmaceutical and biotechnology R&D expenditures, as well as government funding for omics, are expected to drive market growth.

Restraint

High cost associated with the market

The high capital investment requirements and data management concerns are expected to limit the growth of this market to some extent. High research investment, high failure rates, and medication delivery challenges are all issues limiting market growth for firms in this industry.

Global RNA Analysis: Key Players

CD Genomics

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Illumina Inc.
Merck Kgaa
Promega Corp.
Qiagen NV
Thermo Fisher Scientific Inc.
Danaher Corp.
Eurofins Scientific
Fluidigm Corp.
Other Prominent Players

Global RNA Analysis: Regions

Global RNA Analysis market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. North America dominates the global market as a result of intense R&D and rising awareness. Rising demand for personalised medicine and increased R&D investment are expected to provide impetus to the growth and approval of transcriptomics technologies.

Global RNA Analysis is further segmented by region into:

North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Global RNA Analysis report also contains analysis on:

RNA Analysis Segments:

By Type
- Consumables
- Instruments
- Software
- Services
By Application
- Clinical Diagnostics
- Drug Discovery
- Toxicogenomics
- Comparative Transcriptomics
RNA Analysis Dynamics
RNA Analysis Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints

RNA Analysis Market Report Scope and Segmentation

REPORT ATTRIBUTE	DETAILS
Market size value in 2021	USD 14.96 billion
Revenue forecast in 2031	USD 4.12 billion
Growth Rate	CAGR of 12.4% from 2021 to 2031
Base year for estimation	2020
Quantitative units	Revenue in USD million and CAGR from 2021 to 2030
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered	Type, Application and Region
Regional scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Key companies profiled	CD Genomics, Illumina Inc., Merck Kgaa, Promega Corp., Qiagen NV, Thermo Fisher Scientific Inc., Danaher Corp., Eurofins Scientific, Fluidigm Corp. and Other Prominent Players .

Frequently Asked Questions (FAQ):

RNA Analysis market size was estimated at USD 4.96 billion in 2021 and is expected to reach USD 14.12 billion in 2031.

Drug Discovery and consumables accounted for the largest RNA Analysis market share.

Key players: CD Genomics, Illumina Inc., Merck Kgaa, Promega Corp., Qiagen NV are the key players in the RNA Analysis market.

The increasing demand for personalised medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding for omics, and the increasing applications of RNA sequencing in the transcriptomics market are driving the growth of this market.